Validation of screening tool for ROS1 gene rearrangements

Posted by on May 11, 2016 4:25 pm
Categories: health

Immunohistochemistry (IHC) is an effective tool that can be used for identifying proto-oncogene 1 receptor tyrosine kinase (ROS1) gene rearrangements and screening patients for the administration of the targeted therapy crizotinib, a small-molecule tyrosine kinase inhibitor.

Leave a Reply

Your email address will not be published. Required fields are marked *